share_log

Clearmind Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.

SEC announcement ·  Feb 6 22:57
Summary by Futu AI
An amendment to Schedule 13G has been filed with the United States Securities and Exchange Commission by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, reporting a change in their holdings of Clearmind Medicine Inc. common shares. As of December 31, 2023, the reporting persons collectively hold 88,925 shares, representing approximately 4.99% of the company's common stock. This ownership includes shares issuable upon the exercise of two warrants held by Intracoastal Capital LLC. The amendment, filed on February 6, 2024, indicates that the shares were not acquired for the purpose of changing or influencing the control of Clearmind Medicine Inc. and are not held in connection with any transaction having that purpose or effect.
An amendment to Schedule 13G has been filed with the United States Securities and Exchange Commission by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, reporting a change in their holdings of Clearmind Medicine Inc. common shares. As of December 31, 2023, the reporting persons collectively hold 88,925 shares, representing approximately 4.99% of the company's common stock. This ownership includes shares issuable upon the exercise of two warrants held by Intracoastal Capital LLC. The amendment, filed on February 6, 2024, indicates that the shares were not acquired for the purpose of changing or influencing the control of Clearmind Medicine Inc. and are not held in connection with any transaction having that purpose or effect.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.